Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Brigit Biofarmaka Technologi Tbk (OBAT) Fair Value & Analysis

Consumer Defensive · ID · Market cap 121B IDR

Price246.00 IDR
Fair Value729.02 IDR
Upside+196.3%
Quality81/100
Evidence: Medium Range 417.05 IDR – 1,003 IDR

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Brigit Biofarmaka Technologi Tbk (OBAT) currently trades at 246.00 IDR, while our model-based Fair Value estimate is 729.02 IDR — implying the stock looks roughly 196.3% undervalued today. We read business quality at 81/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

PT Brigit Biofarmaka Technologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, and hair serum and powder, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. In addition, it provides lip gloss, cushion, foundation, eyeliner, and blush on balm. The company was founded in 2015 and is based in Sukoharjo, Indonesia.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is PT Brigit Biofarmaka Technologi Tbk (OBAT) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 729.02 IDR versus a price of 246.00 IDR — about +196% (undervalued). Model-based estimate, not financial advice.
What is the fair value of OBAT?
Our 21-model fair value for PT Brigit Biofarmaka Technologi Tbk is 729.02 IDR (as of Jun 25, 2026), built from audited fundamentals. The current price is 246.00 IDR.
What is the quality score of OBAT?
PT Brigit Biofarmaka Technologi Tbk has a Quality Score of 81/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.